Angiopoietin-like proteins: Potential new targets for metabolic syndrome therapy

Yuichi Oike, Masaki Akao, Yoshiaki Kubota, Toshio Suda

Research output: Contribution to journalReview articlepeer-review

118 Citations (Scopus)


Metabolic syndrome is an increasingly prevalent problem, so effective therapeutic approaches to combat it are currently of interest. Recently, orphan ligands with structural similarity to angiopoietins were identified in the systemic circulation, and have been designated angiopoietin-like proteins (Angptls). Angptl3 and Angptl4 have been shown to regulate fat, lipid or glucose metabolic homeostasis. More recently, AGF (also called Angptl6) has been shown to counteract obesity and related insulin resistance. Notably, these factors are secreted mainly from the liver and act as endocrine signals in the peripheral tissues, suggesting a new role for hepatocyte-derived factors in regulating metabolic homeostasis. As more is discovered about the functions of Angptls, so their potential as therapeutic targets for metabolic syndrome is explored.

Original languageEnglish
Pages (from-to)473-479
Number of pages7
JournalTrends in Molecular Medicine
Issue number10
Publication statusPublished - 2005

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology


Dive into the research topics of 'Angiopoietin-like proteins: Potential new targets for metabolic syndrome therapy'. Together they form a unique fingerprint.

Cite this